• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: U.S.

Fidelity Advisor Biotechnology Fund

+ Add to Watchlist

FBTBX:US

19.69 USD 0.27 1.39%

As of 09:29:30 ET on 09/16/2014.

Snapshot for Fidelity Advisor Biotechnology Fund (FBTBX)

Year To Date: +17.60% 3-Month: +9.93% 3-Year: +40.93% 52-Week Range: 14.81 - 20.76
1-Month: +3.03% 1-Year: +23.61% 5-Year: +26.28% Beta vs MXWO: 1.10

Mutual Fund Chart for FBTBX

No chart data available.
  • FBTBX:US 19.69
  • 1M
  • 1Y
Interactive FBTBX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBTBX

Fidelity Advisor Biotechnology Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund normally invests at least 80% of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes.

Inception Date: 12-27-2000 Telephone: 1-877-208-0098
Managers: RAJIV KAUL
Web Site: advisor.fidelity.com

Fundamentals for FBTBX

NAV (on 2014-09-16) 19.69
Assets (M) (on 2014-08-29) 1,741.05
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 0.00

Dividends for FBTBX

Dividend Type Long Term Cap Gain
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-09-05) 0.18
Dividend Yield (ttm) 1.20

Fees & Expenses for FBTBX

Front Load 0.00
Back Load 5.00
Current Mgmt Fee 0.55
Redemption Fee 0.75
12b1 Fee 1.00
Expense Ratio 1.94

Top Fund Holdings for FBTBX

Filing Date: 07/31/2014
Name Position Value % of Total
Gilead Sciences Inc 2,554,512 233,865,574 15.285%
Celgene Corp 1,073,361 93,543,411 6.114%
Vertex Pharmaceuticals Inc 951,126 84,564,613 5.527%
Biogen Idec Inc 170,990 57,177,346 3.737%
Amgen Inc 415,017 52,869,016 3.455%
Alexion Pharmaceuticals Inc 322,999 51,353,611 3.356%
Regeneron Pharmaceuticals Inc 158,080 49,988,058 3.267%
Puma Biotechnology Inc 198,084 43,919,184 2.870%
Intercept Pharmaceuticals Inc 168,060 39,050,422 2.552%
InterMune Inc 804,065 35,274,332 2.305%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil